Building A Biosimilar ‘Launch Machine’ For MENA – MS Pharma CEO Sets Out Strategy

Kalle Känd Explains How MS Pharma Is Seeking To Lead On Biosimilars

 
• By Dave Wallace
  
Kalle Känd talks to Generics Bulletin for an exclusive interview (MS Pharma)

More from Interviews

More from Leadership